Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps
- 1School of Medical Sciences, Shandong Xiehe University, Jinan 250109, China
- 2Department of Physical Activity, Faculty of Education and Science, Rada’a, Albaydha University, Albaydha 14517, Yemen
Abstract
Socotra (Yemen) is home to several resin-producing plant groups. This review evaluates the phytochemistry, biological activities, and safety of Dracaena cinnabari, Socotran Boswellia, and Commiphora resins, identifies gaps in the available evidence, and distinguishes resin-derived findings from bark-derived evidence. D. cinnabari resin contains homoisoflavans and chalcones, but quantitative data for major phenolics remain insufficient. Resin preparations showed antifungal and radical-scavenging activity in vitro; a resin extract and two chalcone derivatives reduced hepatitis B virus antigen production in culture without establishing antiviral efficacy. A methanolic resin extract was cytotoxic to six oral squamous cell carcinoma lines (half-maximal inhibitory concentration [IC50]: 5.9–19.2 µg/mL). Two rat carcinogenesis protocols reported 14.3% carcinoma incidence at 1000 mg/kg versus 85.7% in carcinogen-only controls. A single study of acute and 28-day oral toxicity provides limited, extract-specific safety data. Boswellia and Commiphora resin chemistry is documented mainly through volatile profiles. B. elongata resin yielded 21 compounds, including boswellic acids, whose presence does not establish pharmacological equivalence to B. serrata or B. sacra; four triterpenoid acids inhibited yeast α-glucosidase (IC50 9.9–56.8 µM), but antidiabetic efficacy was not tested. Most other Boswellia bioactivity data concern bark. (+)-Yangambin accounted for 3.50–9.05% (w/w) of recovered C. ornifolia ethanol extracts. No eligible bioassays of Commiphora resins or human studies were identified. The evidence does not support therapeutic claims.
Related
- Pak choi (Brassica rapa L. subsp. chinensis): Phytochemical Diversity, Biological Activities, and Emerging Applications in Nutrition, Health and Cosmetics
- Phytochemical Analysis and Biological Activities of Essential Oils from Leaves and Stems of Dicranopteris pedata (Houtt.) Nakaike
- Assessment of Antioxidant Capacity, Phytochemical Phenolic Composition, Cholinesterase and α-Glucosidase Inhibitory Activities, and Antimicrobial Potential of Tribulus terrestris
- Phytochemical analyses, antimicrobial, antioxidant and anticancer activities of endophytic fungi from leaves of Reseda pruinosa
- Phytochemical Profile and Cosmeceutical Potential of Lotus germanicus: Antioxidant, Anti-Tyrosinase, Anti-Elastase and Antibacterial Activities of Parent Plant and In Vitro Cultures
BibTeX
@article{noman2026medicinal,
title = {{Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps}},
author = {Abeer Essam Noman and Naif S. Al-Barha and Fuad A. Abdu},
journal = {Molecules},
year = {2026},
month = oct,
doi = {10.3390/molecules31213904},
url = {https://www.mdpi.com/1420-3049/31/21/3904},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps
AU - Abeer Essam Noman
AU - Naif S. Al-Barha
AU - Fuad A. Abdu
PY - 2026
DA - 2026/10/29
JO - Molecules
DO - 10.3390/molecules31213904
UR - https://www.mdpi.com/1420-3049/31/21/3904
AB - Socotra (Yemen) is home to several resin-producing plant groups. This review evaluates the phytochemistry, biological activities, and safety of Dracaena cinnabari, Socotran Boswellia, and Commiphora resins, identifies gaps in the available evidence, and distinguishes resin-derived findings from bark-derived evidence. D. cinnabari resin contains homoisoflavans and chalcones, but quantitative data for major phenolics remain insufficient. Resin preparations showed antifungal and radical-scavenging activity in vitro; a resin extract and two chalcone derivatives reduced hepatitis B virus antigen production in culture without establishing antiviral efficacy. A methanolic resin extract was cytotoxic to six oral squamous cell carcinoma lines (half-maximal inhibitory concentration [IC50]: 5.9–19.2 µg/mL). Two rat carcinogenesis protocols reported 14.3% carcinoma incidence at 1000 mg/kg versus 85.7% in carcinogen-only controls. A single study of acute and 28-day oral toxicity provides limited, extract-specific safety data. Boswellia and Commiphora resin chemistry is documented mainly through volatile profiles. B. elongata resin yielded 21 compounds, including boswellic acids, whose presence does not establish pharmacological equivalence to B. serrata or B. sacra; four triterpenoid acids inhibited yeast α-glucosidase (IC50 9.9–56.8 µM), but antidiabetic efficacy was not tested. Most other Boswellia bioactivity data concern bark. (+)-Yangambin accounted for 3.50–9.05% (w/w) of recovered C. ornifolia ethanol extracts. No eligible bioassays of Commiphora resins or human studies were identified. The evidence does not support therapeutic claims.
SN - 1420-3049
ER -